Experienced Director of Process Development and biochemist with over 20 years of R&D experience in the vaccine industry and as a consultant in bioprocess
development and characterization. Martin specializes in evaluating biophysical properties and industrial-scale viability of novel biopharmaceutical products, having directly contributed to the success of eight clinical or latestage development candidates as a leader in protein purification and characterization teams.